Literature DB >> 16504245

Trophic transfer of paralytic shellfish toxins from clams (Ruditapes philippinarum) to gastropods (Nassarius festivus).

Man-Chi Choi1, Peter K N Yu, Dennis P H Hsieh, Paul K S Lam.   

Abstract

A local strain of the dinoflagellate Alexandrium tamarense (ATCI01), which predominantly produces C2 toxin, was fed to the clams (Ruditapes philippinarum) under laboratory conditions. Concentrations of paralytic shellfish toxins (PSTs) in the dosed clams were determined by High Performance Liquid Chromatographic (HPLC) analyses, and the clams were homogenized and then fed to the gastropods (Nassarius festivus). In the toxin accumulation phase, which lasted for 42 days, concentrations of PSTs increased in the snails gradually, reaching a maximum of 1.10 nmole g(-1) at the end of the exposure period. The toxin content of the homogenized clams (food) was 13.18 nmole g(-1), which was about 12-fold higher than the PST content in the snails. Between day 43 and day 82, the snails were fed with non-toxic clams, and this period represented the depuration phase. Accumulation and depuration rates of PSTs in the snails, N. festivus, were determined by fitting the experimental data to user-defined parameters program using a one-compartment model. Two different modeling approaches were used to derive the accumulation and depuration rates. The first approach is to derive both values from the data for the toxin uptake. The second approach is to derive depuration rate from the depuration data and then to derive uptake rate, allowing for toxin depuration, from the data for toxin uptake. The first approach yielded more consistent results for the toxin concentration at the end of the uptake period, when compared with the experimental data. The toxin uptake and depuration rates were 1.64 (pmole of toxin into snail per day) per (nmole g(-1) of toxin in food) and 0.06+/-0.02 day(-1) (mean+/-SE), respectively. The toxin profiles of snails were similar to the clams, but different from the algae. Besides C toxins (C1 and C2), dcGTX2 and dcGTX3 were also detected in both clams and snails. The beta:alpha epimer ratio gradually decreased during trophic transfer and approached a ratio of 1:3 (26.4 mol%:73.6 mol% at day 42) in the snails, near the end of the accumulation period.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16504245     DOI: 10.1016/j.chemosphere.2006.01.036

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  5 in total

1.  Liza ramada Juveniles after Exposure to the Toxic Dinoflagellate Vulcanodinium rugosum: Effects on Fish Viability, Tissue Contamination and Microalgae Survival after Gut Passage.

Authors:  Aurélien Bouquet; Marie Anaïs Perdrau; Mohamed Laabir; Elodie Foucault; Nicolas Chomérat; Jean Luc Rolland; Eric Abadie
Journal:  Toxins (Basel)       Date:  2022-06-10       Impact factor: 5.075

2.  Persistent Contamination of Octopuses and Mussels with Lipophilic Shellfish Toxins during Spring Dinophysis Blooms in a Subtropical Estuary.

Authors:  Luiz L Mafra; Daiana Lopes; Vanessa C Bonilauri; Hajime Uchida; Toshiyuki Suzuki
Journal:  Mar Drugs       Date:  2015-06-18       Impact factor: 5.118

Review 3.  Bioactive Compounds Isolated from Neglected Predatory Marine Gastropods.

Authors:  Ashlin H Turner; David J Craik; Quentin Kaas; Christina I Schroeder
Journal:  Mar Drugs       Date:  2018-04-05       Impact factor: 5.118

Review 4.  Non-traditional vectors for paralytic shellfish poisoning.

Authors:  Jonathan R Deeds; Jan H Landsberg; Stacey M Etheridge; Grant C Pitcher; Sara Watt Longan
Journal:  Mar Drugs       Date:  2008-06-10       Impact factor: 5.118

5.  The Common Sunstar Crossaster papposus-A Neurotoxic Starfish.

Authors:  Karl J Dean; Ryan P Alexander; Robert G Hatfield; Adam M Lewis; Lewis N Coates; Tom Collin; Mickael Teixeira Alves; Vanessa Lee; Caroline Daumich; Ruth Hicks; Peter White; Krista M Thomas; Jim R Ellis; Andrew D Turner
Journal:  Mar Drugs       Date:  2021-12-07       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.